NCT03869060View on ClinicalTrials.gov

Expansion of a Dengue-1 Live Virus Human Challenge

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

September 20, 2019

Study Completion Date

September 20, 2019

Conditions
Dengue
Interventions
BIOLOGICAL

Dengue-1 Virus-Live Virus Human Challenge (DENV-1-LVHC)

Dengue subtype 1 Challenge Virus (DENV-1) strain 45AZ5

Trial Locations (1)

13210

State University of New York, Upstate Medical University (SUNY-UMU), Syracuse

All Listed Sponsors
collaborator

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

collaborator

U.S. Army Medical Research and Development Command

FED

lead

State University of New York - Upstate Medical University

OTHER

NCT03869060 - Expansion of a Dengue-1 Live Virus Human Challenge | Biotech Hunter | Biotech Hunter